Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with the most significant upgrade forecasted for a biopharmaceutical firm.
投資分析師本週上調了六隻主要股票的目標股價，其中一家公司預計將上漲82％。修訂後的目標包括四家美國上市公司，預計生物製藥公司的上調幅度最大。
What Happened: CNBC Pro conducted a screening for global stocks that have garnered price target upgrades from five or more analysts in the past seven days and exhibit a potential upside of over 25%, the report published on Friday.
發生了什麼：週五發佈的報告顯示，CNBC Pro對在過去七天內獲得五位或更多分析師上調目標股價且潛在上漲幅度超過25％的全球股票進行了篩選。
The upgraded stocks include Shift4 Payments Inc (NYSE:FOUR), Semtech Corp (NASDAQ:SMTC), Formula One Group, and MacroGenics Inc (NASDAQ:MGNX) from the U.S., along with South Korea's Hyundai Motor (OTC:HYMTF) and France's Vusion.
升級後的股票包括來自美國的Shift4 Payments Inc（紐約證券交易所代碼：FOUR）、Semtech Corp（納斯達克股票代碼：SMTC）、一級方程式集團和MacroGenics Inc（納斯達克股票代碼：MGNX），以及韓國的現代汽車（場外交易代碼：HYMTF）和法國的Vision。
This week, MacroGenics Investment banks raised their price target for the biopharmaceutical company MacroGenics, predicting an 83% upside over the next year. The company's latest trial data for its vobra-duo drug, which showed a significantly improved safety profile, was cited as a potential catalyst for increased efficacy.
本週，MacroGenics投資銀行提高了生物製藥公司MacroGenics的目標股價，預計明年將上漲83％。該公司最新的vobra-duo藥物試驗數據顯示出顯著改善的安全性，被認爲是提高療效的潛在催化劑。
According to the report, "We highlight that an improved safety profile with lower discontinuations and dose reductions could lead to better exposure and consequently better efficacy vs. prior data," said JMP analyst Silvan Tuerkcan in a note to clients on Apr. 3.
根據該報告，JMP分析師Silvan Tuerkcan在4月3日給客戶的一份報告中說：“我們強調，與先前的數據相比，通過減少停藥和減少劑量來改善安全狀況，從而提高暴露量，從而提高療效。”
Despite a 15% drop in Shift4 Payments shares over the past month following the board's rejection of several takeover bids, investment banks are urging clients to buy, citing the stock's attractive levels. Analysts also suggested that Shift4 could benefit from the $30 billion settlement Visa and MasterCard reached with the U.S. government to limit credit and debit card fees charged to businesses, according to the report.
儘管在董事會拒絕了幾項收購要約後，Shift4 Payments的股價在過去一個月中下跌了15％，但投資銀行以該股的誘人水平爲由敦促客戶買入。報告稱，分析師還表示，Shift4可能會受益於Visa和萬事達卡與美國政府達成的300億美元和解協議，該協議旨在限制向企業收取的信用卡和借記卡費用。
Why It Matters: These upgrades come amid a period of market uncertainty. In late February, Ned Davis Research suggested that the current bull market in stocks is only halfway through its potential.
爲何重要：這些升級是在市場不確定時期進行的。2月下旬，內德·戴維斯研究公司表示，當前的股票牛市只是其潛力的一半。
However, in March, several reports indicated potential market corrections. A leading research firm suggested that global stock markets may be nearing a correction. At the same time, Paul Dietrich, the chief investment strategist at B. Riley Wealth, warned that the stock market is "bizarrely" overvalued and a major correction is imminent.
但是，在三月份，幾份報告顯示市場可能出現調整。一家領先的研究公司表示，全球股市可能接近修正。同時，B. Riley Wealth首席投資策略師保羅·迪特里希警告說，股市 “奇怪地” 被高估了，重大調整迫在眉睫。
Despite these warnings, Bank of America predicted a potential surge of 34% in the S&P 500 by the end of 2026. These conflicting views underscore the current market volatility and the potential opportunities for investors willing to take on risk.
儘管有這些警告，但美國銀行預測，到2026年底，標準普爾500指數可能上漲34％。這些相互矛盾的觀點凸顯了當前的市場波動以及願意承擔風險的投資者的潛在機會。
Image Via Shutterstock
圖片來自 Shutterstock
譯文內容由第三人軟體翻譯。